| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Treace Medical Concepts, Inc. (TMCI) has 7 insiders with recent SEC Form 4 filings, including 9 buys and 1 sell. TMCI is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 7.32M | $25.71M | +50.0K | |
| CFO | 952.0K | $3.34M | - | |
| Other | 794.9K | $2.79M | - | |
| Other | 704.7K | $2.47M | - | |
| Other | 342.9K | $1.20M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Treace John T.60 | Chief Executive Officer | Buy | 50,000 | $3.56 | $177,915.00 | +0.7% | - | - | |
| Mar 17, 2025 | Scanlan Sean F.65 | Chief Innovation Officer | Sale+OE | 50,000 | $7.97 | $398,460.00 | -12.1% | -27.7% | -81.7% | |
| Mar 4, 2025 | Treace John T.60 | Chief Executive Officer | Buy | 60,000 | $8.73 | $524,064.00 | +0.9% | -35.1% | -83.4% | |
| Sep 16, 2024 | Treace John T.60 | Chief Executive Officer | Buy | 50,000 | $5.31 | $265,630.00 | +0.8% | +51.5% | +41.1% | |
| Aug 15, 2024 | Treace James T53 | Director | Buy | 84,000 | $5.96 | $501,034.80 | +7.4% | +32.4% | +15.2% | |
| Aug 14, 2024 | Treace John T.60 | Chief Executive Officer | Buy | 85,000 | $6.00 | $510,314.50 | +1.3% | +47.0% | +27.1% | |
| Jun 11, 2024 | Treace John T.60 | Chief Executive Officer | Buy | 45,000 | $5.88 | $264,600.00 | +0.7% | -11.3% | +5.5% | |
| May 31, 2024 | Treace James T53 | Director | Buy | 25,000 | $6.05 | $151,327.50 | +2.2% | +6.6% | -2.4% | |
| May 29, 2024 | Treace James T53 | Director | Buy | 25,000 | $5.20 | $130,062.50 | +2.3% | +16.3% | +11.0% | |
| May 28, 2024 | Treace James T53 | Director | Buy | 50,000 | $5.07 | $253,475.00 | +4.8% | +24.4% | +15.8% |